XOMA Royalty (XOMA) Times Interest Earned (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Times Interest Earned came in at -$0.14 in Q1 2026, down 108.36% year-on-year from $1.71 in Q1 2025, and up 82.84% quarter-over-quarter from -$0.83 in Q4 2025.
XOMA Royalty (XOMA) Times Interest Earned (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Times Interest Earned across 14 years of filings, most recently posting -$0.14 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$0.14, down 108.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.02 (up 101.07% YoY), and the FY2025 annual result was $0.51, up 117.75% from the prior year.
- Times Interest Earned came in at -$0.14 for Q1 2026 at XOMA Royalty, up from -$0.83 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1.71 in Q1 2025 to a low of -$4.48 in Q3 2024.
- The 3-year median for Times Interest Earned is -$0.83 (2025), against an average of -$1.09.
- Across the five-year window, Times Interest Earned surged 186.7% in 2025 and tumbled 108.36% in 2026, its largest moves.
- XOMA Royalty's Times Interest Earned stood at -$2.14 in 2024, then jumped by 61.03% to -$0.83 in 2025, then soared by 82.84% to -$0.14 in 2026.
- The last three Times Interest Earned figures came in at -$0.14 (Q1 2026), -$0.83 (Q4 2025), and -$0.4 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | XOMA Royalty | 5.49 Mn | -60.59 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.83 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | 1.42 |
| Mar 31, 2025 | 1.71 |
| Dec 31, 2024 | -2.14 |
| Sep 30, 2024 | -4.48 |
| Jun 30, 2024 | -2.96 |
| Mar 31, 2024 | -1.97 |
| Jun 30, 2021 | -17.81 |
| Mar 31, 2021 | -22.24 |
| Dec 31, 2020 | 66.31 |
| Sep 30, 2020 | -6.20 |
| Jun 30, 2020 | -6.20 |
| Mar 31, 2020 | -10.36 |
| Dec 31, 2019 | -6.86 |
| Sep 30, 2019 | 5.97 |
| Jun 30, 2019 | -11.14 |
| Mar 31, 2019 | 4.51 |
| Dec 31, 2018 | -9.38 |